SNBL USA appoints vp of business development
Mark Crane takes overall responsibility for marketing, sales and business development
Crane takes responsibility for the company’s marketing, sales and business development efforts. He joins SNBL USA from Ricerca Biosciences where he was vice president of global sales and marketing.
Crane has held similar positions at Bridge Pharmaceutical (formerly GeneLogic), Quest Pharmaceutical Services, and MDS Pharma Services.
SNBL USA is a subsidiary of Shin Nippon Biomedical Laboratories (SNBL), one of the largest CROs in Japan.
You may also like
Research & Development
![Rethinking the route to first-in-human studies]()
Rethinking the route to first-in-human studies
For sponsors, development activities and fragmented clinical supply can slow the path from candidate selection to first-in-human (FIH) dosing. A more integrated approach can reduce avoidable complexity while preserving the flexibility needed for early clinical programmes
Research & Development
![Stablepharma doses first participant in Phase IIb trial of fridge-free tetanus-diphtheria vaccine]()
Stablepharma doses first participant in Phase IIb trial of fridge-free tetanus-diphtheria vaccine
The 160-person non-inferiority study is the final development step for the StablevaX-reformulated vaccine SPVX02, before commercialisation of a cold-chain-independent alternative to Tetadif
Manufacturing
![Making blister package integrity testing decisions that QA can use]()
Making blister package integrity testing decisions that QA can use
A blister package integrity testing strategy should give QA evidence that is relevant, repeatable, and practical to review. That means understanding the pack format, the likely leak risk, the sampling approach, and the records needed for routine decisions
